ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
11 2020
Historique:
received: 29 06 2020
accepted: 04 07 2020
pubmed: 17 7 2020
medline: 15 4 2021
entrez: 17 7 2020
Statut: ppublish

Résumé

Radiotherapy (RT) plays a major role in the treatment of small cell lung cancer (SCLC). Therefore, the ACROP committee was asked by ESTRO to provide recommendations on target volume delineation for standard clinical scenarios in definitive (chemo)-radiotherapy (CRT), adjuvant RT for stages I-III SCLC and consolidation thoracic RT for stage IV disease. The aim of these guidelines is to standardise and optimise the process of RT treatment planning for clinical practice and prospective studies. The process for the development of the guidelines included the evaluation of a structured questionnaire followed by a consensus discussion, voting and writing process within the committee. Firstly, we provide recommendations for both the imaging to be performed as part of the diagnostic work-up and for the RT planning process. Secondly, recommendations are made for target volume delineation including delineation of the primary gross tumour volume (GTV) and lymph node GTV and clinical tumour volume (CTV) expansion in the context of definitive and adjuvant RT. With regard to internal target volume (ITV) and planning target volume (PTV) definitions, we make recommendations about the management of geometric uncertainties and target motion. Finally, we provide our opinions on organ at risk (OAR) delineation and organisational issues to be considered.

Identifiants

pubmed: 32673777
pii: S0167-8140(20)30405-9
doi: 10.1016/j.radonc.2020.07.012
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-95

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Cecile Le Pechoux (C)

Department of Radiation Oncology, Gustave Roussy, Institut d'Oncologie Thoracique (IOT), Villejuif, France. Electronic address: cecile.lepechoux@gustaveroussy.fr.

Corinne Faivre-Finn (C)

Division of Cancer Sciences, University of Manchester and The Christie NHS Foundation Trust, Manchester, UK.

Sara Ramella (S)

Radiation Oncology, Campus Bio-Medico University of Rome, Italy.

Fiona McDonald (F)

Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK.

Farkhad Manapov (F)

Department of Radiation Oncology, University Hospital, LMU Munich, Germany.

Paul Martin Putora (PM)

Department of Radiation Oncology, Kantonsspital St. Gallen, Switzerland; Department of Radiation Oncology, University of Bern, Switzerland.

Ben Slotman (B)

Department of Radiation Oncology, Amsterdam University Medical Center-location VUMC, Amsterdam, The Netherlands.

Dirk De Ruysscher (D)

Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Center+, GROW Research Institute, Maastricht, The Netherlands.

Umberto Ricardi (U)

Department of Oncology, University of Turin, Italy.

Xavier Geets (X)

Department of Radiation Oncology, Cliniques universitaires Saint-Luc, MIRO - IREC Lab, UCL, Belgium.

José Belderbos (J)

Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Christoph Pöttgen (C)

Department of Radiation Oncology, West German Tumor Centre, University of Duisburg-Essen Medical School, Germany.

Rafal Dziadiuszko (R)

Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland.

Stephanie Peeters (S)

Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Center+, GROW Research Institute, Maastricht, The Netherlands.

Yolande Lievens (Y)

Department of Radiation Oncology, Ghent University Hospital and Ghent University, Ghent, Belgium.

Coen Hurkmans (C)

Catharina Hospital, Department of Radiation Oncology, Eindhoven, The Netherlands.

Paul Van Houtte (P)

Department of Radiation Oncology, Institut Bordet, Université Libre Bruxelles, Belgium.

Ursula Nestle (U)

Department of Radiation Oncology, Kliniken Maria Hilf, Moenchengladbach, Germany; Department of Radiation Oncology, University Hospital Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH